Beta-adrenergic blocking drugs.
There are currently six beta-adrenoceptor blocking drugs on the market. Although all the drugs competitively interact with the beta-adrenergic receptors, their pharmacokinetics and ancillary properties distinguish them from one another. By understanding these differences, the various beta-adrenoceptor drugs can be rationally used to a therapeutic advantage.
Gerber
J G
JG
Nies
A S
AS
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D006321:Heart / Q000187:drug effects; D006327:Heart Block / Q000139:chemically induced; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007473:Ion Channels / Q000187:drug effects; D007700:Kinetics; D008055:Lipids; D009203:Myocardial Infarction / Q000517:prevention & control; D011928:Raynaud Disease / Q000139:chemically induced; D012964:Sodium / Q000378:metabolism; D013375:Substance Withdrawal Syndrome
D000319:Adrenergic beta-Antagonists; D007473:Ion Channels; D008055:Lipids; D012964:Sodium